Fig 1: PI3K is a direct target of pachymic acid. (A) Molecular docking of pachymic acid with PI3K (PDB ID: 1E7U). (B) Molecular docking of pachymic acid with Akt (PDB ID: 4GV1). (C) RMSD of pachymic acid with PI3K. (D) RMSF of pachymic acid with PI3K. (E) SPR analysis of pachymic acid and PI3K interaction (KD = 5.89 × 10−5 mol/L).
Fig 2: Pachymic acid reduces tight junction protein degradation via the PI3K/Akt pathway. Representative expression of p‐PI3K, PI3K, p‐Akt, and Akt proteins detected by Western blot (A) and quantitative analysis (B‐C, n = 4). (D) Representative expression of ZO‐1, Occludin, and Claudin‐5 proteins detected by Western blot (n = 4). (E) Quantitative analysis of ZO‐1 protein (n = 4). (F) Quantitative analysis of Occludin protein (n = 4). (G) Quantitative analysis of Claudin‐5 protein (n = 4). & p < 0.05, and && p < 0.01 and &&& p < 0.001 vs. Sham; **p < 0.01 vs. tPA + vehicle; ▲ p < 0.05 and ▲▲ p < 0.01 vs. tPA + pachymic acid‐80 mg/kg. Data are expressed as mean ± SD.
Supplier Page from Sino Biological, Inc. for PI3K (p110 alpha (E542K)/p85 alpha), Active